Latest filing published 04 Apr 2016 for BG Medicine, Inc., €5,488.
Insider track record
Stephen P. Hall: trading record in brief
This profile gathers the share dealings of Stephen P. Hall across 4 companies, led by BG Medicine, Inc., Helicos Biosciences Corp and Stemline Therapeutics Inc. The record holds 7 filings, for trades running from 20 December 2005 to 31 March 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 April 2016 came the latest disclosure, a share grant for €5,488 in BG Medicine, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephen P. Hall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,530 shares@ US$0.8365.9% of flowCommon StockSEC:0001209191-16-112629:0
- 8,986 shares@ US$0.3634.1% of flowCommon StockSEC:0001209191-16-112632:0
- 7,505 shares@ US$0.83Common StockSEC:0000899243-15-003612:0
- 190,200 shares0Common StockSEC:0001181431-14-034473:0
- 40,000 shares0Common StockSEC:0001104659-13-050779:0
- 50,000 shares0Common StockSEC:0001179110-09-001713:0
- 2,474 shares@ US$9.25Common StockSEC:0000908662-06-000411:0
7 of 7 declarations
